Expression of receptor for advanced glycation end products (RAGE) in human biliary cancer cells

被引:2
|
作者
Hirata, K [1 ]
Takada, M [1 ]
Suzuki, Y [1 ]
Kuroda, Y [1 ]
机构
[1] Kobe Univ, Grad Sch Med Sci, Dept Surg Gastroenterol, Chuo Ku, Kobe, Hyogo 6500017, Japan
关键词
RAGE; biliary cancer; invasion;
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/Aims: Amphoterin is considered as a regulator for the ability of invasion and migration in tumor cells and embryonic neurons through binding to RAGE (receptor for advanced glycation end products), a multiligand cell surface molecule of the immunoglobulin superfamily: Methodology: To see the involvement of RAGE in biliary cancer, three representative human biliary cancer cells (SK-ChA-1, TGBC-1 and NOZC-1) were rendered for the study. Cell invasion ability was determined using Matrigel invasion assay. The expression of RAGE protein was studied by Western blotting. Results: Cell invasion assay through Matrigel showed high invasion potential in SK-ChA-1 and NOZC-1 (40.3+/-3.27, 48.7+/-4.8); low invasion potential in TGBC-1 (25.7+/-2.8). RAGE was strongly expressed in SK-ChA-1 and NOZC-1 that have high invasion ability. On the contrary, RAGE was faintly expressed in TGBC-1 that has low ability. Conclusions: RAGE is expressed in concordance to the invasion ability of the human biliary cancer cells. Control of this molecule could be a key to regulate the invasion ability of biliary cancers.
引用
收藏
页码:1205 / 1207
页数:3
相关论文
共 50 条
  • [1] Expression of receptor for advanced glycation end products (RAGE) and MMP-9 in human pancreatic cancer cells
    Takada, M
    Hirata, K
    Ajiki, T
    Suzuki, Y
    Kuroda, Y
    HEPATO-GASTROENTEROLOGY, 2004, 51 (58) : 928 - 930
  • [2] Receptor for advanced glycation end products (RAGE) expression in non melanoma skin cancer
    Valdes-Rodriguez, Rodrigo
    Javier Gonzalez, Francisco
    Castillo-Martinez, Claudio
    Renteria-Palomo, Ana-Arely
    Torres Alvarez, Bertha
    Fuentes-Ahumada, Cornelia
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2011, 131 : S28 - S28
  • [3] Developmental expression and regulation of receptor for advanced glycation end products (RAGE)
    Reynolds, Paul R.
    Huecksteadt, Tom P.
    Sturrock, Anne
    Hoidal, John R.
    DEVELOPMENTAL BIOLOGY, 2006, 295 (01) : 379 - 379
  • [4] Overexpression of receptor for advanced glycation end products (RAGE) in ovarian cancer
    Rahimi, Farzaneh
    Karimi, Jamshid
    Goodarzi, Mohammad Taghi
    Saidijam, Massoud
    Khodadadi, Iraj
    Razavi, Amir Nader Emami
    Nankali, Maryam
    CANCER BIOMARKERS, 2017, 18 (01) : 61 - 68
  • [5] Hypoxia and the Receptor for Advanced Glycation End Products (RAGE) Signaling in Cancer
    Taneja, Sakshi
    Vetter, Stefan W.
    Leclerc, Estelle
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (15)
  • [6] Understanding RAGE, the receptor for advanced glycation end products
    Bierhaus, A
    Humpert, PM
    Morcos, M
    Wendt, T
    Chavakis, T
    Arnold, B
    Stern, DM
    Nawroth, PP
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2005, 83 (11): : 876 - 886
  • [7] The Receptor for Advanced Glycation End Products (RAGE) and the Lung
    Buckley, Stephen T.
    Ehrhardt, Carsten
    JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY, 2010,
  • [8] Understanding RAGE, the receptor for advanced glycation end products
    Angelika Bierhaus
    Per M. Humpert
    Michael Morcos
    Thoralf Wendt
    Triantafyllos Chavakis
    Bernd Arnold
    David M. Stern
    Peter P. Nawroth
    Journal of Molecular Medicine, 2005, 83 : 876 - 886
  • [9] Dysregulation of Receptor for Advanced Glycation End Products (RAGE) Expression as a Biomarker of Keratoconus
    Navel, Valentin
    Malecaze, Jean
    Belville, Corinne
    Choltus, Helena
    Henrioux, Fanny
    Dutheil, Frederic
    Malecaze, Francois
    Chiambaretta, Frederic
    Blanchon, Loic
    Sapin, Vincent
    DISEASE MARKERS, 2022, 2022
  • [10] Increased Expression of the Receptor for Advanced Glycation End-Products (RAGE) Is Associated with Advanced Breast Cancer Stage
    Nankali, Maryann
    Karimi, Jamshid
    Goodarzi, Mohammad T.
    Saidijam, Massoud
    Khodadadi, Iraj
    Razavi, Amir N. Emami
    Rahimi, Farzaneh
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 (10) : 622 - +